NIO Super Specialty Hospital expands its services with new clinics and technology integration: Our Bureau, Bengaluru Tuesday, July 15, 2025, 15:30 Hrs [IST] National Institute of ...

Meril Lifesciences concludes TechVentory programme, driving the future of healthcare supply chains with AI: Our Bureau, ...

Intelligent Bio Solutions to present Pharmacokinetic study data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo: New York Tuesday, July 15, 2025, 15: ...

Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, announced upcoming presentations at ...

Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

Agilus Diagnostics launches new Anti-MCV antibody test that provides early RA diagnosis, improves patient outcomes: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:15 Hrs [IST] A ...

BriaCell Therapeutics Corporation announces updated phase 2 data of Bria-IMT, shows survival advantage over Trodelvy in metastatic breast cancer: Philadelphia & Vancouver, British ...

Elegen, Nutcracker Therapeutics to pilot cell-free manufacturing process for RNA-based personalized cancer therapeutics: San Francisco Tuesday, July 15, 2025, 11:00 Hrs [IST] Eleg ...

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

Study says India’s healthcare set for $50 billion transformation as single-specialty hospitals surge: Our Bureau, Mumbai Tuesday, July 15, 2025, 10:00 Hrs [IST] India’s health ...

Verastem Oncology releases primary results from phase 2 RAMP 201 trial of Avutometinib in combo with defactinib: Boston Tuesday, July 15, 2025, 09:00 Hrs [IST] Verastem Oncology, ...